Our operations span from R&D to grow operations and the development of targeted cannabinoid health solutions for today’s medical issues. This end-to-end business model enables Allied to rapidly identify where people most need help, isolate therapeutic strains to precisely address those unmet needs, and bring unique and effective products to market.